Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Current Deferred Revenue (2024 - 2025)

Historic Current Deferred Revenue for Rallybio (RLYB) over the last 2 years, with Q3 2025 value amounting to $424000.0.

  • Rallybio's Current Deferred Revenue fell 6134.91% to $424000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $424000.0, marking a year-over-year decrease of 6134.91%. This contributed to the annual value of $848000.0 for FY2024, which is N/A changed from last year.
  • Rallybio's Current Deferred Revenue amounted to $424000.0 in Q3 2025, which was down 6134.91% from $636000.0 recorded in Q2 2025.
  • Rallybio's 5-year Current Deferred Revenue high stood at $1.2 million for Q2 2024, and its period low was $424000.0 during Q3 2025.